1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Pharmaceutical Continuous Manufacturing Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Pharmaceutical Continuous Manufacturing Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Shortage of Medicines
- 5.1.2 Advantages Offered by Continuous Manufacturing Process
5.2 Market Opportunities
- 5.2.1 Emerging Markets to Provide High Potential Growth Opportunities
5.3 Future Trends
- 5.3.1 High Capital Investments
5.4 Impact of Drivers and Restraints
6. Europe Pharmaceutical Continuous Manufacturing Market Regional Analysis
6.1 Europe Pharmaceutical Continuous Manufacturing Market Overview
6.2 Europe Pharmaceutical Continuous Manufacturing Market Revenue 2016-2027 (US$ Million)
6.3 Europe Pharmaceutical Continuous Manufacturing Market Forecast Analysis
7. Europe Pharmaceutical Continuous Manufacturing Market Analysis – by Product
7.1 Integrated Systems
- 7.1.1 Overview
- 7.1.2 Integrated Systems: Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Semi-Continuous Systems
- 7.2.1 Overview
- 7.2.2 Semi-Continuous Systems: Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Controls
- 7.3.1 Overview
- 7.3.2 Controls: Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Pharmaceutical Continuous Manufacturing Market Analysis – by Application
8.1 End Product Manufacturing
- 8.1.1 Overview
- 8.1.2 End Product Manufacturing: Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
8.2 API Manufacturing
- 8.2.1 Overview
- 8.2.2 API Manufacturing: Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Pharmaceutical Continuous Manufacturing Market Analysis – by End User
9.1 Full-Scale Manufacturing Companies
- 9.1.1 Overview
- 9.1.2 API Manufacturing: Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
9.2 R&D Departments
- 9.2.1 Overview
- 9.2.2 API Manufacturing: Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
10. Europe Pharmaceutical Continuous Manufacturing Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.1.1.1 Europe Pharmaceutical Continuous Manufacturing Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 UK: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.1.1.1.2 UK: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.1.1.1.3 UK: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
- 10.1.1.2 Germany:
Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Germany: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.1.1.2.2 Germany: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.1.1.2.3 Germany: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
- 10.1.1.3 France:
Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 France: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.1.1.3.2 France: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.1.1.3.3 France: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
- 10.1.1.4 Russia:
Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.4.1 Russia: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.1.1.4.2 Russia: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.1.1.4.3 Russia: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
- 10.1.1.5 Italy:
Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.5.1 Italy: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.1.1.5.2 Italy: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.1.1.5.3 Italy: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
- 10.1.1.6 Rest of Europe:
Europe Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.1.1.6.2 Rest of Europe: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.1.1.6.3 Rest of Europe: Europe Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Pharmaceutical Continuous Manufacturing Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Fette Compacting
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 KORSCH AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 LEISTRITZ AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 ALEXANDERWERK AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Hovione
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights